remove_red_eye 744 Views
#Pathology and Lab Medicine #Pulmonary Medicine
Researchers have developed a simple blood test, which relies on DNA sequencing that can detect when a newly transplanted lung is being rejected by a patient, even when no outward signs of the rejection are evident. The test could make it possible for doctors to intervene faster to prevent or slow down so-called chronic rejection—which is severe, irreversible, and often deadly—in those first critical months after lung transplantation. Researchers believe this same test might also be useful for monitoring rejection in other types of organ transplants. The study’s findings were published Jan. 22, 2018 in EBioMedicine.